Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials. (Q50862543)
Jump to navigation
Jump to search
scientific article published on 13 March 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials. |
scientific article published on 13 March 2017 |
Statements
Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials (English)
A Frassoldati
D Generali
G Bisagni
L Cavanna
K Cagossi
A Michelotti
R Berardi
G Banna
A Goubar
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference